Parent Project July 2006v5
-
Upload
heart-of-the-valley-pediatric-cardiology -
Category
Documents
-
view
219 -
download
0
Transcript of Parent Project July 2006v5
-
8/8/2019 Parent Project July 2006v5
1/68
Muscular DystrophyMuscular Dystrophy
Parent Project Muscular Dystrophy2006 Annual Conference
Cincinnati, 2006.
Doug Biggar, MD, FRCP(C)
Bloorview Kids Rehab, Toronto.
Treatment with Corticosteroids
-
8/8/2019 Parent Project July 2006v5
2/68
Why Corticosteroids in DMD?Why Corticosteroids in DMD?
Prednisone shown to change the course of DMD
reduced weakness
preserved motor function
but ..taken daily is best and
side effects common
-
8/8/2019 Parent Project July 2006v5
3/68
-
8/8/2019 Parent Project July 2006v5
4/68
Corticosteroids in DMDCorticosteroids in DMD
Summary:
Corticosteroids help muscle strength
They slow the progression
Start when boys are walking
Best to give every day, once a day
Balanced discussion of benefits and risks More studies are needed
-
8/8/2019 Parent Project July 2006v5
5/68
Derivative of prednisone
Similar effects on:
What is Deflazacort?What is Deflazacort?
immunity
inflammation
-
8/8/2019 Parent Project July 2006v5
6/68
Less:
weight gain
diabetes
osteoporosis?behavior problems
Why Deflazacort?Why Deflazacort?
Same benefits as prednisone but fewer
side effects
-
8/8/2019 Parent Project July 2006v5
7/68
Deflazacort in DMDDeflazacort in DMD
Treatment protocol
Results: Mobility
Pulmonary Function
Scoliosis
Heart
-
8/8/2019 Parent Project July 2006v5
8/68
Arbitrary, 4 6 years of age
When parents tell us:
stairs are more difficult
falling more
difficulty getting up from floor
they are ready
Time to StartTime to Start
-
8/8/2019 Parent Project July 2006v5
9/68
0.9 mgm / kgm / day
Starting DoseStarting Dose
then adjust with: age
weight
side effects
-
8/8/2019 Parent Project July 2006v5
10/68
Deflazacort DoseDeflazacort Dose
Average dose at:
10 years.0.8s 0.18 mg/kg/day
15 years.0.55s 0.1 mg/kg/day
18 years.0.5s 0.2 mg/kg/day
-
8/8/2019 Parent Project July 2006v5
11/68
Deflazacort Group - 48 boysv.s.
No Deflazacort Group - 33 boys
Deflazacort Treatment ofDuchenne Muscular Dystrophy
Deflazacort Treatment ofDuchenne Muscular Dystrophy
-
8/8/2019 Parent Project July 2006v5
12/68
33 boys
age 9 19 years
NoNo Deflazacort GroupDeflazacort Group
concerns about side effects: weight gain
behavior
not walking
other
parental choice
-
8/8/2019 Parent Project July 2006v5
13/68
48 boys
start age 4-6 years
Deflazacort GroupDeflazacort Group
starting dose:
0.9 mgm/kg/day- one dose
1000 units Vitamin D and
750 mg Calcium
-
8/8/2019 Parent Project July 2006v5
14/68
normal weight gain
preserved muscle strength
preserved cardiac function
preserved pulmonary function
delayed or prevented scoliosis
Our Findings Since 90Our Findings Since 90
-
8/8/2019 Parent Project July 2006v5
15/68
Osteoporosis even without steroids
30-70% cataracts, not treated
some behaviour issues- muddy waters
puberty delayed
short stature- good and bad
Our Findings Since 90Our Findings Since 90
:
-
8/8/2019 Parent Project July 2006v5
16/68
-
8/8/2019 Parent Project July 2006v5
17/68
-
8/8/2019 Parent Project July 2006v5
18/68
-
8/8/2019 Parent Project July 2006v5
19/68
-
8/8/2019 Parent Project July 2006v5
20/68
-
8/8/2019 Parent Project July 2006v5
21/68
-
8/8/2019 Parent Project July 2006v5
22/68
-
8/8/2019 Parent Project July 2006v5
23/68
-
8/8/2019 Parent Project July 2006v5
24/68
-
8/8/2019 Parent Project July 2006v5
25/68
-
8/8/2019 Parent Project July 2006v5
26/68
-
8/8/2019 Parent Project July 2006v5
27/68
-
8/8/2019 Parent Project July 2006v5
28/68
-
8/8/2019 Parent Project July 2006v5
29/68
-
8/8/2019 Parent Project July 2006v5
30/68
-
8/8/2019 Parent Project July 2006v5
31/68
-
8/8/2019 Parent Project July 2006v5
32/68
-
8/8/2019 Parent Project July 2006v5
33/68
-
8/8/2019 Parent Project July 2006v5
34/68
-
8/8/2019 Parent Project July 2006v5
35/68
-
8/8/2019 Parent Project July 2006v5
36/68
PreservedPreserved
Muscle FunctionMuscle Function
-
8/8/2019 Parent Project July 2006v5
37/68
WalkingWalking
stop at 9.8 1.8 years
No deflazacort - 33 boys
-
8/8/2019 Parent Project July 2006v5
38/68
treated with deflazacort 48 boys
15 stopped walking at 12.7 s 2.9 years
on average, walk 3-5 years longer
WalkingWalking
-
8/8/2019 Parent Project July 2006v5
39/68
Two Different Protocols forTwo Different Protocols for
DeflazacortDeflazacort
Two Different Protocols forTwo Different Protocols for
DeflazacortDeflazacort
Protocol-N Protocol-T
4-8 Start (years) 6-8
0.6 mg/kg Dose 0.9 mg/kg
20 days on
10 days off
Schedule Daily
As needed for
osteoporosis
Vitamin D
Calcium
1000 units
750 mg
Naples Toronto
-
8/8/2019 Parent Project July 2006v5
40/68
MobilityMobility Walk 10 metresWalk 10 metresMobilityMobility Walk 10 metresWalk 10 metres
9 36/37 (97) 32/32 (100) 15/31 (48)
12 9/26 (35) 19/23 (83) 0/31 (0)
15 3/12 (25) 10/13 (77) 0/31 (0)
Age TorontoNaples Control
-
8/8/2019 Parent Project July 2006v5
41/68
PreservedPreserved
Pulmonary FunctionPulmonary Function
-
8/8/2019 Parent Project July 2006v5
42/68
PULMONARY FUNCTION
0
20
40
60
80
100
10 15 18
FVC
PercentPredicte
Untreated
Treated
Age in years
-
8/8/2019 Parent Project July 2006v5
43/68
Pulmonary FunctionPulmonary Function
At 18 years, boys on deflazacort have:
a better cough
fewer admissions to hospital forpneumonia
no increased infection
and none need nocturnal ventilation
-
8/8/2019 Parent Project July 2006v5
44/68
Delayed ScoliosisDelayed Scoliosis
-
8/8/2019 Parent Project July 2006v5
45/68
Criteria For Spine SurgeryCriteria For Spine Surgery
progressive curve (20 degrees +)
pulmonary function (greater than 40%)
-
8/8/2019 Parent Project July 2006v5
46/68
No deflazacort
27/33 boys done at 13.75 years s 3.6
6/33 not done
3 spines straight at 20 years
3 refused
Scoliosis Surgery in DMDScoliosis Surgery in DMD
-
8/8/2019 Parent Project July 2006v5
47/68
Deflazacort treated:
36 boys older than
13years
4/36 have had surgery
2- compliance issues
2- age 14 and 17 years
Scoliosis Surgery in DMDScoliosis Surgery in DMD
-
8/8/2019 Parent Project July 2006v5
48/68
ScoliosisScoliosis -- Boys after13yrs.Boys after13yrs.ScoliosisScoliosis -- Boys after13yrs.Boys after13yrs.
0%
30%
60%
90%
Naples Toronto Control
30%*
16%*
*p
-
8/8/2019 Parent Project July 2006v5
49/68
Arm FunctionArm Function
Feeding and self care preserved for 5-6 years
-
8/8/2019 Parent Project July 2006v5
50/68
DilemmaDilemma
how long will my sons spine stay
straight?
who will operate on his spine if he
needs surgery?
-
8/8/2019 Parent Project July 2006v5
51/68
Preserved
Cardiac Function
Preserved
Cardiac Function
-
8/8/2019 Parent Project July 2006v5
52/68
C tr l Defl z c ort P
A + + NS
LVEF(< %) % %
% f ti n l
h t nin + +
Cardiac FunctionCardiac Function
-
8/8/2019 Parent Project July 2006v5
53/68
What about his bones?What about his bones?
-
8/8/2019 Parent Project July 2006v5
54/68
What makes bones healthy?What makes bones healthy?
Genetics
Physical activity
Other things: calcium, vitamin D etc
-
8/8/2019 Parent Project July 2006v5
55/68
What about my sonsWhat about my sons
bones?bones?Even young have reduced bone density
Worse with reduced walking
~25% have long bone fractures
Vertebral (back bone) fractures dont occur
-
8/8/2019 Parent Project July 2006v5
56/68
OsteoporosisOsteoporosis
Bisphosphonates (fosamax)
not approved for children
side-effects?
effective?
growing bone?
-
8/8/2019 Parent Project July 2006v5
57/68
Osteoporosis StudyOsteoporosis Study
Summary
Alendronate (fosamax)
well tolerated
minimal side effects
improved lumbar spine bone density
not approved for children
-
8/8/2019 Parent Project July 2006v5
58/68
Bottom LineBottom Line
More questions than answers
Most boys have osteoporosis
Why measure bone mineral density?
Does it help you manage boys better?
Does it predict the risk of fractures?
-
8/8/2019 Parent Project July 2006v5
59/68
Bottom LineBottom Line
Probably worse with deflazacort
Risk of fractures, controversial
long bones vertebrae
Can be treated, if indicated
More research needed
-
8/8/2019 Parent Project July 2006v5
60/68
Incidence of FracturesIncidence of FracturesIncidence of FracturesIncidence of Fractures
5%
10%
15%
20%
25%
Naples Toronto Control
-
8/8/2019 Parent Project July 2006v5
61/68
Benefits of deflazacort appear to
outweigh side effects
ConclusionsConclusions
Majorbenefits of preserved: walking
pulmonary function
cardiac function straight spine
arm and hand function
-
8/8/2019 Parent Project July 2006v5
62/68
CataractsCataracts
70% of boys after10 years
Small Eye sight normal
No treatment needed
-
8/8/2019 Parent Project July 2006v5
63/68
Psychosocial IssuesPsychosocial Issues
difficult to know
we need more research
very, very important
-
8/8/2019 Parent Project July 2006v5
64/68
ConclusionsConclusions
Side effects:
weight height
cataracts
osteoporosis delayed puberty
-
8/8/2019 Parent Project July 2006v5
65/68
No hypertension
No diabetes
No renal stones
No liver problems
No increased fractures
ConclusionsConclusions
-
8/8/2019 Parent Project July 2006v5
66/68
What dont we know?What dont we know?
Lots.
What age to start?
What is the best dose to start with? Does he have to take it every day?
What is the dose over the next years?
When, if ever, do you stop? What will happen if I stop steroids?
-
8/8/2019 Parent Project July 2006v5
67/68
For more information:For more information:
Articles:Deflazacort Treatment of Duchenne Muscular Dystrophy:
Doug Biggar, et al.
Journal ofPaediatrics, 45 - 50, 2001.
Effects of Deflazacort on Left Ventricular Function in Patients With
Duchenne Muscular Dystrophy: Silversides C. et al.
American Journal of Cardiology, Vol. 91, 769, 2003.
Steroid Treatment and the Development ofScoliosis in Males with
Duchenne Muscular Dystrophy: Alman, B.A. et al.
Journal of Bone and Joint Surgery, Vol. 86, 519- 524, 2004
Long-term benefits of deflazacort treatment for boys with DMD in
their second decade: Doug Biggar, et al.
Neuromuscular Disorders, 16, 249-255, 2006.
-
8/8/2019 Parent Project July 2006v5
68/68
Deflazacort Treatment in
Duchenne MuscularDystrophy
Parent Project MuscularDystrophyCincinnati, Ohio
July 2003
Doug Biggar, MD, FRCP(C)
Thank You!Thank You!